☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
safety
Amgen Reports Safety & Efficacy Results of Repatha (evolocumab) in OSLER-1 Five-Year Extension Study
November 13, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.